Table: Medipal Holdings -2021/22 group results
May 13 (Reuters)-
Medipal Holdings Corp
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2022 Mar 31, 2021 Mar 31, 2023 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 3.29 trln 3.21 trln 3.33 trln 1.68 trln
(-1.3 pct) (+1.3 pct) (+2.0 pct)
Operating 45.62 38.58 46.50 24.60
(-27.4 pct) (+1.9 pct) (+1.3 pct)
Recurring 62.05 52.97 63.30 32.80
(-22.1 pct) (+2.0 pct) (-2.3 pct)
Net
Net 29.42 23.93 33.50 17.30
(-37.0 pct) (+13.9 pct) (-6.6 pct)
EPS 140.14 yen 113.96 yen 159.55 yen 82.40 yen
EPS Diluted 131.41 yen 106.80 yen
Ann Div 44.00 yen 42.00 yen 46.00 yen
-Q2 Div 21.00 yen 21.00 yen 23.00 yen
-Q4 Div 23.00 yen 21.00 yen 23.00 yen
NOTE - Medipal Holdings Corp.
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=7459.T
Recent news on Medipal Holdings
See all newsBrief: Medipal Holdings Corp Says It Will Buy Back Up To 2% Of Own Shares Worth 10 Billion Yen
Table: Medipal Holdings -2026/27 group forecast
Brief: Medipal Holdings Announces It Has Received Demand For EGM From Shareholder Silchester International Investors
Brief: Silchester International Raises Stake In Medipal Holdings Corp To 11.96% From 11.73%, Filing Shows
Brief: Silchester To Make Proposals Regarding Higher Dividend, Share Buyback, Share Retirement, Composition Of Board Of Directors If No Improvement In Dialogue With Medipal Holdings, Filing Shows